
Feb 21 (Reuters) - bluebird bio Inc BLUE.O:
BLUEBIRD BIO ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY CARLYLE AND SK CAPITAL
BLUEBIRD BIO INC - STOCKHOLDERS TO RECEIVE $3.00 PER SHARE IN CASH
BLUEBIRD BIO INC - DAVID MEEK EXPECTED TO BECOME CEO OF BLUEBIRD UPON CLOSING OF DEAL
BLUEBIRD BIO INC - STOCKHOLDERS TO RECEIVE CONTINGENT VALUE RIGHT OF $6.84 PER SHARE FROM DEAL
BLUEBIRD BIO: ENTERED INTO AMENDMENTS TO LOAN AGREEMENT WITH HERCULES CAPITAL TO FACILITATE ADEQUATE LIQUIDITY
Source text: ID:nBwb7M3fsa
Further company coverage: BLUE.O